Skip to content

ANVS - Annovis Bio, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

Annovis Bio Inc

ANVS · NYSE

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

ANVSAnnovis Bio Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $5.50
52-wk low: $1.54
Prev close: $3.11
Mkt cap: $78.8M
Beta: 1.24
P/B: 25.2x

Smart money

8 funds hold a position and insiders have been net buying.

Real smart money

Funds holding this stock

8 holders

Combined position$7.5M

MW
Marshall Wace
Q2 2026 13F
$3.4M
position
JS
Jim Simons
Q2 2026 13F

Earnings

Reported Aug 11, 2026

Earnings came in 9.1% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $79M

Valuation

P/B25.18

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ANVS
Exchange: NYSE
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $78.82M
Beta: 1.24

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-704.0%

$1.9M

position

TS

Two Sigma

Q2 2026 13F

$1.1M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for ANVS

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.40+9.1%

-$0.44 expected

Next report

What the street expects next

EPS expected

-$0.37

-$0.44 to -$0.30

Revenue expected

$0.00

3 analysts

Last 30 days

0up1down

Analysts cutting estimates

-704.0%

ROA-142.4%

Growth

Beta1.24